Ph. D. Program in Chemical Biology

A Tri-Institutional graduate program that offers training that bridges the diverse scientific cultures and approaches of chemistry and biomedical research.

TRI-INSTITUTIONAL COLLABORATION: a unique training environment

In order to prepare the next generation of scientists to work at the interface of chemistry and biology, the TPCB was established in 2001 to blend the cultures and approaches of these two traditionally distinct disciplines. The Program, now centered among three outstanding New York City-based institutions, combines faculty and resources from Weill Cornell Medical College, Memorial Sloan-Kettering Cancer Center, and The Rockefeller University to prepare students to use chemical tools and principles to solve problems in biology.

RESEARCH

TPCB students are actively engaged in cutting edge research, as evidenced by the impressive list of publications describing their work. The program structure and the depth and breadth of participating faculty ensure that students have significant opportunities both for publications and for presentations at national and international conferences appropriate to their training.

NEW YORK CITY

The three participating institutions, adjacent to each other on Manhattan’s Upper East Side, are an integral part of the robust New York City research environment. The close geographic proximity of the Tri-Institutions provides access for TPCB students to attend lectures and symposia, to avail themselves of extensive library resources and to utilize state-of-the-art instrumentation and cutting-edge technologies required for research.

________________________________________________________________________

TPCB NEWS & ANNOUNCEMENTS
May 2013

TPCB Faculty Member, Christopher D. Lima, PhD, of SKI’s Structural Biology Program, has been selected as a Howard Hughes Medical Institute Investigator. He is one of 27 selected in the recent competition from more than 1,200 applicants. Dr. Lima'’s laboratory uses structural, biochemical and functional analyses of macromolecules to understand RNA metabolism and its role in cell growth and disease. Dr. Lima joins TPCB's three other HHMI investigators: Jonathan Goldberg, Roderick MacKinnon, and Nikola Pavletich, along with HHMI Early Career Scientist Sean Brady.